GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore ...

LONDON (Reuters) -European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices in the Medicaid programme in ...

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. GSK plc (NYSE:GSK) is one of the top performers on Tuesday. Shares of GSK rallied for a third straight day on Tuesday to hit a ...

WASHINGTON >> Pfizer and President Donald Trump on Tuesday said they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program to what it ...

The FTSE 100 reached a new record high as healthcare stocks soared. AstraZeneca and GSK led gains, while real estate bolstered midcaps. Despite manufacturing setbacks and geopolitical uncertainties, ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA interference medicines past the blood-brain barrier.

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...

Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would be next up to cut a deal over drug pricing.

GSK CEO Emma Walmsley will step down in 2025, with Luke Miels taking over as the company refocuses on pipeline growth and Montco operations.

A deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of clarity after a volatile year during which Trump has taken aim at the ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).